Revolution Medicines Inc

Stock Chart, Company Information, and Scan Results

$221.15(as of Aug 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Revolution Medicines Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$221.15
Ticker SymbolRVMD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees883
CountyUSA
Market Cap$43,971.1M
EBIDTA-1,618.3M
10-Day Moving Average212.71
P/E Ratio-26.38
20-Day Moving Average205.53
Forward P/E Ratio0.00
50-Day Moving Average191.80
Earnings per Share-8.87
200-Day Moving Average129.76
Profit MarginUnknown
RSI70.82
Shares Outstanding214.3M
ATR8.16
52-Week High205.90
Volume3,356,829
52-Week Low34.14
Most Recent Support Level198.91
Book Value2,606.2M
Most Recent Resistance Level220.34
P/B Ratio17.90
Upper Keltner223.88
P/S RatioUnknown
Lower Keltner187.18
Debt-to-Equity Ratio0.25
Next Earnings DateUnknown
Cash Surplus461.4M
Next Ex-Dividend DateUnknown

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc In Our Stock Scanner

As of Aug 27, 2026
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.